Richard Smith Consultant Nephrologist Ipswich Hospital Beta cell replacement: Islet and whole pancreas transplantation.

Slides:



Advertisements
Similar presentations
Body Mass Index, Weight and Insulin Dose as Selection Criteria for Islet Transplantation R Smith Bristol UK 29th AIDPIT Workshop Igls.
Advertisements

Diabetes Overview Managing Diabetes in Primary Care.
Clinical islet transplantation Stephanie A Amiel, BSc, MD, FRCP RD Lawrence Professor of Diabetic Medicine Kings College London School of Medicine Diabetes.
Susan Alexander, DNP, CNS, CRNP, BC- ADM College of Nursing University of Alabama in Huntsville Clinical Affiliation: Outpatient Diabetes Self-Management.
Dr. Hemant Gupta [Associate Prof. & Unit Head, Dept of Medicine, J. J
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
Diabetes and dementia Jackie watts Clinical Advisor Diabetes UK.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Kidney, Pancreas & Intestinal Transplantation Mr James Gilbert Consultant Transplant & Vascular Access Surgeon.
Recovery of the β–cell function both in new and long-standing type 2 diabetic patients through long-term treatment with continuous subcutaneous insulin.
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
BACKGROUND ON PANCREAS HISTOLOGICAL FINDINGS: University of Maryland experience John C. Papadimitriou, M.D.,Ph.D. Professor of Pathology.
Concepts in the natural history of diabetes.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
Pancreatic and Islet Cell Transplantation. GENERAL PRINCIPLES Pancreas graft survival rates have significantly improved over the past decade, and now.
CARE OF PATIENTS WITH DIABETES MELLITUS JANNA WICKHAM RN MSN LSSC FALL 2013 Chapter 20.
Insulin in Primary Care Dr Saqib Mahmud, MRCP(UK), MRCGP.
Medical Management of Ulcerative Colitis Conrad Beckett Bradford Royal Infirmary M62 Course March 2006.
Management of Adults with Diabetes undergoing Surgery and Elective Procedures UHL Guideline – April 2013 The aim of the guideline is to improve standards.
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
IMPROVING DIABETES MANAGEMENT IN PRIMARY CARE
Assessment of Radial Pulse Wave Analysis, Insulin Resistance, and Glucose Homeostasis in African Americans at High Risk for Developing Type 2 Diabetes.
Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up Featured Article:
DIABETES MELLITUS IN CHILDREN. Blood glucose Apart from transient illness-induced or stress-induced hyperglycemia, a random whole-blood glucose.
HEFT - Good Hope Gestational diabetes service. HEFT – Good Hope, Birmingham Heartlands and Solihull Hospitals Two very different patient populations >12000.
Section 5: Configuration of healthcare to manage CKD.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Diabetes National Diabetes Control Programme
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Nursing Management: Diabetes Mellitus
Transplantation in the Diabetic Patient The Status of Pancreas transplantation A. Osama Gaber Professor of Surgery Director of the Transplant Institute,
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 1 of 3.
Part 4.
Heart Failure Heart failure (HF) is a common clinical syndrome. Heart failure (HF) is a complex clinical syndrome that can result from any structural or.
Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver Operating Characteristic Analysis Featured.
Diabetes And Hemodialysis 1 Dr.Ruba Nashawati. 2.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
Diabetic Profile Measurement of Blood Glucose T.A. Bahiya Osrah.
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
ANTENATAL CARE OF DIABETES IN PREGNANCY: AUDIT Rachael Read ST2 O&G Supervisor: Mr E Njiforfut Consultant.
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Islet cell transplantation Rob Crookston. Advanced Nurse Practitioner. Oxford University Hospitals NHS Foundation Trust.
Lab (7): Diabetic profile
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomized open-label controlled trial Yves.
Whole blood was the sample of choice for analysis However, values for glucose in whole blood are less than in plasma since red blood cells contain only.
Heart Failure Services at STH: How it works and how End of Life issues are addressed Dr Soon H Song Consultant Diabetologist Acute Medicine Lead for STH.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Aetiology of preoperative anaemia in patients undergoing elective cardiac surgery Jacob Abhrahm 1,Romi Sinha 2,Kathryn Robinson 3, David Cardone 1 1 Department.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Part 5. Insulin Resistance and  -Cell Dysfunction: Summary Individuals with impaired glucose tolerance –Are maximally or near-maximally insulin resistant.
Diabetes & Driving- DVLA rules
BLOOD OR PLASMA GLUCOSE
Department of Internal Medicine
Care of Patients with Diabetes Mellitus
Beta Cell Transplantation Richard Smith Consultant Senior Lecturer
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
Monitoring in Type 2 Diabetes
Section 5: Configuration of healthcare to manage CKD
Figure 1 Timeline of pancreatic islet transplantation
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
Effect of PIs on insulin release by downstream insulin secretogogues.
Comparison of the regression lines for AIRarg (the acute insulin response to intravenous arginine over 2–5 min after injection) and AIRargMAX (the response.
Zn2+ and NAD(P)H content in Mafa∆panc and Mafa∆panc;Mafb+/− β-cells.
Somatostatin released by δ-cells exerts a tonic inhibition on glucagon and insulin secretion but is not required for the glucagonostatic effect of glucose.
Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

Richard Smith Consultant Nephrologist Ipswich Hospital Beta cell replacement: Islet and whole pancreas transplantation

Whole pancreas usually transplanted as simultaneous kidney pancreas transplant Should be considered for all patients with type 1 diabetes listed for kidney transplantation Solitary pancreas transplantation also performed May be pancreas transplantation alone (PTA) or pancreas after kidney transplant (PAK) Indication is usually severe hypoglycaemia

Whole pancreas usually transplanted as simultaneous kidney pancreas transplant Should be considered for all patients with type 1 diabetes listed for kidney transplantation Solitary pancreas transplantation also performed May be pancreas transplantation alone (PTA) or pancreas after kidney transplant (PAK) Indication is usually severe hypoglycaemia Islet transplantation is usually performed as islet transplant alone (ITA). May also be performed as islet after kidney transplant Indication is severe hypoglycaemia

Figure 4a: Islet registrations by patient residence Figure 4b: Isolated pancreas registrations by patient residence Registrations by Strategic Health Authority – Maps, 1 February to 31 July 2011 * Three additional patients had overseas postcodes (including one from the Republic of Ireland)

Bristol Manchester Newcastle Royal Free Kings Oxford Edinburgh Single allocation scheme for whole pancreas and islet transplantation

3 Indications for pancreas transplant alone 3.1 Criteria Presence of insulin dependent type 1 diabetes mellitus Significant diabetic complications Life threatening complications ie frequent and severe episodes of hypoglycaemia Hypoglycaemia unawareness Impairment of quality of life Other metabolic or behavioural problems causing referral by a diabetologist Indications: PTA

3 Indications for pancreas transplant alone 3.1 Criteria Presence of insulin dependent type 1 diabetes mellitus Significant diabetic complications Life threatening complications ie frequent and severe episodes of hypoglycaemia Hypoglycaemia unawareness Impairment of quality of life Other metabolic or behavioural problems causing referral by a diabetologist. Indications: PTA

Indications: ITA Severe hypoglycaemia Two or more episodes of hypoglycaemia requiring outside help in the previous 6 months Hypoglycaemia unawareness

Outcomes: UK SPK 1 April 2003 to 31 March 2009 Pancreas graft survivalPatient survival

Outcomes: UK PTA/PAK 1 April 2003 to 31 March 2009 Pancreas graft survivalPatient survival

Islet transplantation: Bristol 3 Patients 1 achieved insulin independence with first transplant Acute graft failure 3 months post transplant 1 achieved complete resolution of hypoglycaemic for 1 year Reduction in insulin dose Has now received pancreas transplant 1 achieved resolution of hypoglycaemia with one transplant Second transplant achieved insulin independence Remains insulin independent

UK Outcomes 54 islet infusions in 34 recipients 27 ITA 6 IAK 1 SIK 1 infusion n=16 2 infusions n=16 3 infusions n=2 96% graft function at one month Severe hypoglycaemia reduced by >95% HbA 1c reduced (8.4% vs 7.0%) International Outcomes ( infusions in 571 recipients 1 infusion 31% 2 infusions 47% 3 infusions 20% >3 2% Graft survival 40-80% five years 70% patients free of severe hypoglycaemia at 1 year 18 deaths over mean of 6 years follow up

Hypoglycaemia

In ‘typical’ month 1 patient admitted to GRH with acute abdomen 1 patient admitted to Moreton in the Marsh with chest pain 1 patient admitted to Cheltenham with chest pain 1 patient joint care with obstetrics 1 patient joint care with urology 3 patients referred for gastroenterology opinion 1 patient referred to pain clinic (peripheral neuropathy)

Summary of tests to assess function FPG/RBG/HbA1c 75g Oral Glucose Tolerance Test Mixed Meal Tolerance Test Arginine Intravenous Glucose Tolerance Test

PatientOGTTHbA1c (%)Fasting Glucose (mmol/L) 3 m12 m3 m12 m3 m12 m 1 (SPK) (PAK) (PTA) (PTA) (SPK) (PAK) Outcomes: Glycaemic control

PatientOGTTHbA1c (%)Fasting Glucose (mmol/L) 3 m12 m3 m12 m3 m12 m 1 (SPK)NGT (PAK)NGT (PTA)NGT (PTA)NGT (SPK)IGT (PAK)DGT % of patients have normal OGTT at 1 year post transplant Outcomes: Glycaemic control

NGT Outcomes: Glycaemic control

Outcomes: Beta cell function Acute insulin response to glucose Acute insulin response to arginine Arginine intravenous glucose tolerance test 3 months post transplant

Islet Dysfunction Islet Dysfunction Functioning Islets Pancreas Dysfunction Functioning Pancreas Diabetes Insulin Independence Baidal et al, Transplantation 2009, 87(5): Miami IsletsPancreas MMTTDysF (n=9)F (n=5)AbNGT (n=3)NGT (n= 15) Basal Glucose Basal C-peptide min Glucose min C-peptide IVGTT AIR glucose AIR arginine

Miami IsletsBristol Islets MMTTF (n=5)DysF 2 (n=9)Patient 2Patient 3 Basal Glucose Basal C-peptide min Glucose min C-peptide IVGTT AIR glucose AIR arginine

ArginineGlucose

Pancreas Transplantation ?

Islet Transplantation ? May not work!

International and UK outcomes support whole pancreas transplantation International results support islet transplantation UK results support islet transplantation also Patients presented clearly benefitted These results are from early phase of program At this time not ticking boxes associated with good outcome

Islet versus whole pancreas transplant ? Risk aversity Comorbidity Whole PancreasIslet

Neither whole pancreas or islet transplantation are best for all patients Choice is predicated on being able to achieve successful islet transplantation UK islet transplant outcomes are now good enough to justify islet transplantation’s place alongside whole pancreas transplantation

Primary indication the same: severe hypoglycaemia Islet transplant for the more risk averse patient or patient with comorbidity precluding whole pancreas transplantation Whole pancreas transplantation may be preferable for the patient in whom additional benefit might accrue from better more sustained glycaemic control

Further information Diapedia Islet transplantation – an overview 2014 Diapedia Rev no 4 Available from Pancreas transplantation 2014 Diapedia Rev no 6 Available from Also: